Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Combination immunotherapy including OncoVEXmGMCSF creates a favorable tumor immune micro-environment in transgenic BRAF murine melanoma.
Journal: Cancer immunology, immunotherapy : CII
Published: June 08, 2021
FLT-PET At 6 Weeks Predicts Response Assessed by CT at 12 Weeks in Melanoma Patients Treated With Pembrolizumab.
Journal: Clinical nuclear medicine
Published: February 29, 2020
Identification of a predominant cognitive phenotype in patients with multiple sclerosis.
Journal: European journal of neurology
Published: August 01, 2019
Linking Transcriptomic and Imaging Data Defines Features of a Favorable Tumor Immune Microenvironment and Identifies a Combination Biomarker for Primary Melanoma.
Journal: Cancer research
Published: July 22, 2019
Prognostic and theranostic 18F-FDG PET biomarkers for anti-PD1 immunotherapy in metastatic melanoma: association with outcome and transcriptomics.
Journal: European journal of nuclear medicine and molecular imaging
Published: March 28, 2019
Prognostic and Predictive Immunohistochemistry-Based Biomarkers in Cancer and Immunotherapy.
Journal: Hematology/oncology clinics of North America
Published: March 06, 2019
Validation of Melanoma Immune Profile (MIP), a Prognostic Immune Gene Prediction Score for Stage II-III Melanoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 06, 2018
Unusual Features of Sodium Taurocholate Cotransporting Polypeptide as a Hepatitis B Virus Receptor.
Journal: Journal of virology
Published: June 14, 2016
Identification of Tumor Antigen AF20 as Glycosylated Transferrin Receptor 1 in Complex with Heat Shock Protein 90 and/or Transporting ATPase.
Journal: PloS one
Published: April 12, 2016
Showing 1-9 of 9
Last Updated: 09/26/2026